This article is more than 1 month old.

Bharat Biotech gets DCGI nod for clinical trial of Covaxin for the 2-18 age groups

Mini

Bharat Biotech, the producer of the indigenously developed COVID-19 vaccine Covaxin, has been given the go ahead to start conducting Phase II/III trials of the vaccine for children.

Bharat Biotech gets DCGI nod for clinical trial of Covaxin for the 2-18 age groups

Market Movers

CompanyPriceChange%Loss
Adani Ports718.70 -24.20
Wipro540.15 -16.40
Divis Labs4,224.60 -64.15
JSW Steel665.50 -9.75
Larsen1,479.25 -19.95
CompanyPriceChange%Loss
Kotak Mahindra1,736.80 -23.20
Larsen1,479.80 -19.35
Tata Steel1,099.80 -13.75
TCS3,262.10 -38.55
Axis Bank732.40 -7.20
CompanyPriceChange%Loss
Adani Ports718.70 -24.20 -3.26
Wipro540.15 -16.40 -2.95
Divis Labs4,224.60 -64.15 -1.50
JSW Steel665.50 -9.75 -1.44
Larsen1,479.25 -19.95 -1.33
CompanyPriceChange%Loss
Kotak Mahindra1,736.80 -23.20 -1.32
Larsen1,479.80 -19.35 -1.29
Tata Steel1,099.80 -13.75 -1.23
TCS3,262.10 -38.55 -1.17
Axis Bank732.40 -7.20 -0.97

Currency

CompanyPriceChng%Chng
Dollar-Rupee74.2700-0.0950-0.13
Euro-Rupee88.5440-0.1910-0.22
Pound-Rupee103.5270-0.1410-0.14
Rupee-100 Yen0.6700-0.0020-0.29